These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Structure and function of botulinum toxin]. Fujii N Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367 [TBL] [Abstract][Full Text] [Related]
27. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc. Kalandakanond S; Coffield JA J Pharmacol Exp Ther; 2001 Mar; 296(3):980-6. PubMed ID: 11181932 [TBL] [Abstract][Full Text] [Related]
28. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Singer C; Weiner WJ Muscle Nerve; 1993 Jun; 16(6):677. PubMed ID: 8389003 [No Abstract] [Full Text] [Related]
29. The effect of poneratoxin on neuromuscular transmission in the rat diaphragm. Hendrich AB; Mozrzymas JW; Konopińska D; Scuka M Cell Mol Biol Lett; 2002; 7(2):195-202. PubMed ID: 12097919 [TBL] [Abstract][Full Text] [Related]
30. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction. Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685 [TBL] [Abstract][Full Text] [Related]
31. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins. Simpson LL J Pharmacol Exp Ther; 1982 Dec; 223(3):695-701. PubMed ID: 6292397 [No Abstract] [Full Text] [Related]
33. [Blockade of the ion channels of the skeletal muscle acetylcholine receptor]. Danilov AF Eksp Klin Farmakol; 1998; 61(6):73-5. PubMed ID: 9929824 [TBL] [Abstract][Full Text] [Related]
34. New evidence for a presynaptic action of prednisolone at neuromuscular junctions. Dal Belo CA; Leite GB; Fontana MD; Corrado AP; Zanandréa Baso AC; Moreno Serra CS; Oliveira AC; Rodrigues-Simioni L Muscle Nerve; 2002 Jul; 26(1):37-43. PubMed ID: 12115947 [TBL] [Abstract][Full Text] [Related]
35. The action of botulinal toxin. Simpson LL Rev Infect Dis; 1979; 1(4):656-62. PubMed ID: 233168 [TBL] [Abstract][Full Text] [Related]
36. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin. Simpson LL J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933 [TBL] [Abstract][Full Text] [Related]
37. Identification of the major steps in botulinum toxin action. Simpson LL Annu Rev Pharmacol Toxicol; 2004; 44():167-93. PubMed ID: 14744243 [TBL] [Abstract][Full Text] [Related]
38. Electrophysiological and ultrastructural analysis of the neuromuscular blockade and miotoxicity induced by the Micrurus nigrocinctus snake venom. Goularte FC; da Cruz-Höfling MA; Corrado AP; Rodrigues-Simioni L Acta Physiol Pharmacol Ther Latinoam; 1999; 49(4):290-6. PubMed ID: 10797872 [TBL] [Abstract][Full Text] [Related]
39. Properties of short-term synaptic depression at larval neuromuscular synapses in wild-type and temperature-sensitive paralytic mutants of Drosophila. Wu Y; Kawasaki F; Ordway RW J Neurophysiol; 2005 May; 93(5):2396-405. PubMed ID: 15845998 [TBL] [Abstract][Full Text] [Related]
40. Ectopic expression of NCAM in skeletal muscle of transgenic mice results in terminal sprouting at the neuromuscular junction and altered structure but not function. Walsh FS; Hobbs C; Wells DJ; Slater CR; Fazeli S Mol Cell Neurosci; 2000 Mar; 15(3):244-61. PubMed ID: 10736202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]